Obinutuzumab Significantly Enhanced ADCC and Improves Overall Survival in CD20+ Primary Mediastinal B-Cell Lymphoma (PMBL) Xenograft NSG Mouse Model

Authors

Aradhana AwasthiFollow
Dina Edani, New York Medical College
Janet Ayello, New York Medical CollegeFollow
Christian KleinFollow
Mitchell S. Cairo, New York Medical CollegeFollow

Document Type

Abstract

Publication Date

9-2018

DOI

10.1111/bjh.15536

Journal Title

British Journal of Haematology

Department

Pediatrics

Second Department

Health Behavior and Community Health

Disciplines

Medicine and Health Sciences

Recommended Citation

Awasthi, A., Edani, D., Ayello, J., Klein, C., & Cairo, M. S. (2018). Obinutuzumab Significantly Enhanced ADCC and Improves Overall Survival in CD20+ Primary Mediastinal B-Cell Lymphoma (PMBL) Xenograft NSG Mouse Model. British Journal of Haematology, 182 (Suppl. 1), 65. https://doi.org/10.1111/bjh.15536